Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
60 Degrees Pharmaceuticals Inc. Common Stock
SXTP | US
1.49
USD-0.06
-3.87%
SXTP | US
About 60 Degrees Pharmaceuticals Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
26/03/2026
Close
1.49
Open
1.49
High
1.55
Low
1.43
View Less
SXTP | US
Risk
281.6
Sharpe
-0.41
Luna's Score
46/100
Recommendation
Hold
Luna says (SXTP | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
137.8%1 month
281.6%3 months
371.7%6 months
266.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
22.23
Ent. to rev.
25.03
PEG
-
Other Fundamentals
EBITDA
-8.89M
MarketCap
2.77M
MarketCap(USD)
2.77M
Div. yield
-
Op. margin
-3.33K
Erngs. growth
-
Rev. growth
100.60
Ret. on equity
-
Short ratio
0.54
Short perc.
1.78
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.26
Range1M
2.26
Range3M
8.28
Volumes: Market Activity
Rel. volume
0.06
Price X volume
235.26K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 22.23 | - | Expensive |
| Ent. to Revenue | 25.03 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 371.71 | - | Riskier |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.04 | 0.25 | Cheaper |
| Market Cap | 2.77M | - | Emerging |
